Results 11 to 20 of about 3,328,268 (306)

Perspective and update: intrapleural fibrinolytic therapy for pleural infections and other forms of pleural organization [PDF]

open access: yesRespiratory Research
Intrapleural fibrinolytic therapy (IPFT), also known as intrapleural enzymatic therapy (IET), has been utilized for decades to treat pleural infections by expediting drainage in patients with pleural organization.
Torry A. Tucker   +2 more
doaj   +2 more sources

 1C-Globulin and Synthetic Fibrinolytic Agents

open access: yesExperimental Biology and Medicine, 1969
SummarySynthetic organic fibrinolytic agents modify on incubation β1C-globulin both in its isolated form and in serum. The compounds suppress complement C' activity of serum. Compounds chemically closely related to the fibrinolytic ones but with no fibrinolytic activity themselves do not affect β1C-globulin or complement C′.
N, Aoki, K N, Von Kaulla
openaire   +3 more sources

Enhanced Production of Fibrinolytic Enzyme from Pseudomonas aeruginosa by Optimization Media Components [PDF]

open access: yesJournal of Applied Sciences and Nanotechnology, 2021
Fibrinolytic enzyme is factor that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases attracted worldwide attention for their elevation morbidity and
Bilal Jasim, Entesar Ali
doaj   +1 more source

Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells. [PDF]

open access: yes, 2012
Mesothelial cells are critical in the pathogenesis of post-surgical intraabdominal adhesions as well as in the deterioration of the peritoneal membrane associated with long-term peritoneal dialysis.
Djafarzadeh, Roghieh   +10 more
core   +14 more sources

Marine Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Biochemical Properties and Thrombolytic Activity

open access: yesMarine Drugs, 2022
Cardiovascular diseases (CVDs) have emerged as a major threat to global health resulting in a decrease in life expectancy with respect to humans. Thrombosis is one of the foremost causes of CVDs, and it is characterized by the unwanted formation of ...
Noora Barzkar   +2 more
doaj   +1 more source

Fibrinolytic Protease Activity of Crude Enzyme from Fermented Sunflower (Helianthus annuus) and Common Bean (Phaseolus vulgaris) seeds by Rhizopus microsporus var. oligosporus FNCC 6010 in Solid State Fermentation

open access: yesBorneo Journal of Pharmacy, 2023
In the entire world, cardiovascular diseases (CVDs) are the main cause of death. For the treatment of CVDs, microbial fibrinolytic enzymes are highly regarded as novel therapeutic candidates.
Rebhika Lusiana   +2 more
doaj   +1 more source

Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity—A Review

open access: yesMolecules, 2023
Functionality of the fibrinolytic system is based on activity of its central enzyme, plasmin, responsible for the removal of fibrin clots. Besides the hemostasis, fibrinolytic proteins are also involved in many other physiological and pathological ...
Joanna Kolodziejczyk-Czepas, Jan Czepas
doaj   +1 more source

The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment

open access: yesInternational Journal of Molecular Sciences, 2023
The fibrinolytic system is a key player in keeping the haemostatic balance, and changes in fibrinolytic capacity can lead to both bleeding-related and thrombosis-related disorders.
C. Hvas, J. Larsen
semanticscholar   +1 more source

Microbial Fibrinolytic Enzymes as Anti-Thrombotics: Production, Characterisation and Prodigious Biopharmaceutical Applications

open access: yesPharmaceutics, 2021
Cardiac disorders such as acute myocardial infarction, embolism and stroke are primarily attributed to excessive fibrin accumulation in the blood vessels, usually consequential in thrombosis.
Chhavi Sharma   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy